Alpine 4 (ALPP) 10-Q 16 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Aug. 04, 2021
Registrant CIK	0001606698
Fiscal Year End	--12-31
Registrant Name	Alpine 4 Holdings, Inc.
SEC Form	10-Q
Period End date	Jun. 30, 2021
Tax Identification Number (TIN)	46-5482689
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	false
Small Business	true
Emerging Growth Company	true
Ex Transition Period	true
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55205
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2525 E Arizona Biltmore Circle
Entity Address, Address Line Two	Suite 237
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85016
City Area Code	480
Local Phone Number	702-2431
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Common Class A
Number of common stock shares outstanding		144,881,317
Common Class B
Number of common stock shares outstanding		8,673,088
Common Class C
Number of common stock shares outstanding		12,500,200

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash	$ 10,457,452	$ 277,738
Restricted Cash	1,400,000	444,845
Accounts receivable, net	10,328,941	6,484,869
Contract assets	2,688,198	717,421
Inventory, net	7,842,668	2,666,602
Prepaid expenses and other current assets	830,361	32,301
Total current assets	33,547,620	10,623,776
Property and equipment, net	20,728,221	19,299,286
Intangible asset, net	29,440,716	7,743,084
Right of use assets, net	4,060,920	581,311
Goodwill	5,866,454	2,084,982
Other non-current assets	383,905	401,744
TOTAL ASSETS	94,027,836	40,734,183
CURRENT LIABILITIES:
Accounts payable	5,337,706	4,854,467
Accrued expenses	4,170,001	2,872,202
Contract liabilities	3,371,787	233,485
Notes payable, current portion	10,062,633	7,100,911
Notes payable, related parties	107,820	238,651
Convertible notes payable, current	357,500	562,242
Financing lease obligation, current portion	608,301	639,527
Operating lease obligation, current portion	763,328	334,500
Total current liabilities	24,779,076	16,835,985
Notes payable, net of current portion	2,946,796	15,201,450
Convertible notes payable, net of current portion	0	1,100,635
Financing lease obligations, net of current portion	15,652,386	15,687,176
Operating lease obligations, net of current portion	3,311,749	269,030
Deferred tax liability	428,199	428,199
TOTAL LIABILITIES	47,118,206	49,522,475
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	0	0
Additional paid-in capital	95,944,854	30,991,978
Accumulated deficit	(49,052,146)	(39,795,401)
Total stockholders' equity (deficit)	46,909,630	(8,788,292)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	94,027,836	40,734,183
Series B Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	5	5
Total stockholders' equity (deficit)	5	5
Series C Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	171	171
Total stockholders' equity (deficit)	171	171
Series D Preferred Stock
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred shares	143	0
Total stockholders' equity (deficit)	143	0
Common Class A
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	14,486	12,636
Total stockholders' equity (deficit)	14,486	12,636
Common Class B
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	867	902
Total stockholders' equity (deficit)	867	902
Common Class C
STOCKHOLDERS' EQUITY (DEFICIT):
Common shares	1,250	1,417
Total stockholders' equity (deficit)	$ 1,250	$ 1,417

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Series B Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 1	$ 1
Preferred Stock, Shares Authorized	100	100
Preferred Stock, Shares Issued	5	5
Preferred Stock, Shares Outstanding	5	5
Series C Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	2,028,572	2,028,572
Preferred Stock, Shares Issued	1,714,286	1,714,286
Preferred Stock, Shares Outstanding	1,714,286	1,714,286
Series D Preferred Stock
Preferred Stock, Par or Stated Value Per Share	$ 3.50	$ 3.50
Preferred Stock, Shares Authorized	1,628,572	1,628,572
Preferred Stock, Shares Issued	1,428,570	0
Preferred Stock, Shares Outstanding	1,428,570	0
Common Class A
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	195,000,000	195,000,000
Common Stock, Shares, Issued	144,828,817	126,363,158
Common Stock, Shares, Outstanding	144,828,817	126,363,158
Common Class B
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares, Issued	8,673,088	9,023,088
Common Stock, Shares, Outstanding	8,673,088	9,023,088
Common Class C
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	15,000,000	15,000,000
Common Stock, Shares, Issued	12,500,200	14,162,267
Common Stock, Shares, Outstanding	12,500,200	14,162,267

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Revenue	$ 14,130,730	$ 9,042,864	$ 22,540,269	$ 17,878,460
Cost of revenue	10,166,670	7,086,848	17,821,590	14,162,700
Gross Profit	3,964,060	1,956,016	4,718,679	3,715,760
Operating expenses:
General and administrative expenses	6,353,075	2,450,613	12,179,763	5,314,002
Impairment loss of intangible assets and goodwill	0	1,111,600	0	1,111,600
Research and development	515,202	0	515,202	0
Total operating expenses	6,868,277	3,562,213	12,694,965	6,425,602
Loss from operations	(2,904,217)	(1,606,197)	(7,976,286)	(2,709,842)
Other income (expenses)
Interest expense	(1,216,587)	(905,842)	(2,688,310)	(2,555,069)
Change in value of derivative liability	0	0	0	2,298,609
Gain (loss) on extinguishment of debt	803,079	(62,951)	803,079	91,641
Gain on forgiveness of debt	159,742	0	589,282	0
Change in fair value of contingent consideration	0	0	0	500,000
Other income	30,706	12,076	15,490	62,135
Total other income (expenses)	(223,060)	(956,717)	(1,280,459)	397,316
Loss before income tax	(3,127,277)	(2,562,914)	(9,256,745)	(2,312,526)
Income tax (benefit)	0	0	0	0
Net loss	$ (3,127,277)	$ (2,562,914)	$ (9,256,745)	$ (2,312,526)
Weighted average shares outstanding:
Weighted Average Number of Shares Outstanding, Basic	161,712,406	131,173,215	158,184,050	129,190,454
Weighted Average Number of Shares Outstanding, Diluted	161,712,406	131,173,215	158,184,050	139,071,976
Earnings Per Share, Basic	$ (0.02)	$ (0.02)	$ (0.06)	$ (0.02)
Earnings Per Share, Diluted	$ (0.02)	$ (0.02)	$ (0.06)	$ (0.03)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Additional Paid-in Capital	Retained Earnings	Total	Series B Preferred Stock	Series C Preferred Stock	Series D Preferred Stock	Common Class A	Common Class B	Common Class C
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	$ 19,763,883	$ (31,745,528)	$ (11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Stock Issued During Period, Value, New Issues	249,606	0	250,000	$ 0	$ 0	$ 0	$ 394	$ 0	$ 0
Stock Issued During Period, Shares, New Issues							3,941,753
Issuance of shares of common stock for modification of debt	330,204	0	330,528	$ 0	0	0	$ 162	0	$ 162
Issuance of shares of common stock for modification of debt, shares				0			1,617,067		1,617,067
Issuance Of Shares Of Common Stock For Penalty	44,670	0	44,700	$ 0	0	0	$ 30	0	$ 0
Issuance Of Shares Of Common Stock For Penalty, Shares				0			300,000
Issuance of shares of common stock for convertible note payable and accrued interest	696,868	0	697,332	$ 0	0	0	$ 464	0	0
Issuance Of Shares Of Common Stock For Compensation, Value	603,061	0	603,463	0	0	0	0	$ 402	0
Issuance Of Shares Of Common Stock For Compensation, Shares								4,023,088
Issuance Of Shares Of Series B Preferred Stock, Value	0	0	5	$ 5	0	0	$ 0	$ 0	0
Issuance Of Shares Of Series B Preferred Stock, Shares				5
Issuance of shares of common stock for convertible note payable and accrued interest, shares				0			4,648,879
Share-based compensation expense	19,556	0	19,556	$ 0	0	0	$ 0	0	0
Net loss	0	250,388	250,388	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2019	19,763,883	(31,745,528)	(11,970,142)	$ 0	$ 0	$ 0	$ 10,007	$ 500	$ 996
Shares, Outstanding, Beginning Balance at Dec. 31, 2019				0	0	0	100,070,161	5,000,000	9,955,200
Net loss			(2,312,526)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2020	21,727,404	(34,058,054)	(12,317,528)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Jun. 30, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2020	21,707,848	(31,495,140)	(9,774,170)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Beginning Balance at Mar. 31, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Share-based compensation expense	19,556	0	19,556	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Net loss	0	(2,562,914)	(2,562,914)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2020	21,727,404	(34,058,054)	(12,317,528)	$ 5	$ 0	$ 0	$ 11,057	$ 902	$ 1,158
Shares, Outstanding, Ending Balance at Jun. 30, 2020				5	0	0	110,577,860	9,023,088	11,572,267
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Value	54,301,997	0	54,302,982	$ 0	$ 0	$ 0	$ 985	$ 0	$ 0
Issuance Of Shares Of Common Stock For Cash, Net Of Offering Costs, Shares							9,857,397
Issuance of shares of common stock for convertible note payable and accrued interest	109,760	0	109,830	0	0	0	$ 70	0	0
Stock Issued During Period, Value, Acquisitions	6,653,166	0	6,653,309	0	0	$ 143	0	0	0
Stock Issued During Period, Shares, Acquisitions						1,428,570
Repurchase Of Class C Common Stock, Value	(185,845)	0	(185,850)	0	0	$ 0	$ 0	0	(5)
Issuance of shares of common stock for convertible note payable and accrued interest, shares							702,877
Share-based compensation expense	19,341	0	19,341	0	0	0	$ 0	0	0
Beneficial conversion feature on convertible notes	92,428	0	92,428	0	0	0	0	0	0
Net loss	0	(6,129,468)	(6,129,468)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Ending Balance at Mar. 31, 2021				5	1,714,286	1,428,570	136,923,432	9,023,088	14,117,267
Repurchase Of Class C Common Stock, Shares									(45,000)
Stockholders' Equity Attributable to Parent, Beginning Balance at Dec. 31, 2020	30,991,978	(39,795,401)	(8,788,292)	$ 5	$ 171	$ 0	$ 12,636	$ 902	$ 1,417
Shares, Outstanding, Beginning Balance at Dec. 31, 2020				5	1,714,286	0	126,363,158	9,023,088	14,162,267
Net loss			(9,256,745)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	95,944,854	(49,052,146)	46,909,630	$ 5	$ 171	$ 143	$ 14,486	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Jun. 30, 2021				5	1,714,286	1,428,570	144,828,817	8,673,088	12,500,200
Stockholders' Equity Attributable to Parent, Beginning Balance at Mar. 31, 2021	91,982,825	(45,924,869)	46,074,280	$ 5	$ 171	$ 143	$ 13,691	$ 902	$ 1,412
Shares, Outstanding, Beginning Balance at Mar. 31, 2021				5	1,714,286	1,428,570	136,923,432	9,023,088	14,117,267
Issuance of shares of common stock for convertible note payable and accrued interest	1,419,034	0	1,419,568	$ 0	$ 0	$ 0	$ 534	$ 0	$ 0
Stock Issued During Period, Value, Acquisitions	2,535,007	0	2,535,071	0	0	0	$ 64	0	0
Stock Issued During Period, Shares, Acquisitions							643,010
Issuance of shares of common stock for convertible note payable and accrued interest, shares							5,295,308
Conversion of Class C to Class A, Value	0	0	0	0	0	0	$ 162	0	$ (162)
Conversion of Class C to Class A, Shares							1,617,067		(1,617,067)
Conversion of Class B to Class A, Value	0	0	0	0	0	0	$ 35	$ (35)	$ 0
Conversion of Class B to Class A, Shares							350,000	(350,000)
Share-based compensation expense	7,988	0	7,988	0	0	0	$ 0	$ 0	0
Net loss	0	(3,127,277)	(3,127,277)	0	0	0	0	0	0
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	$ 95,944,854	$ (49,052,146)	$ 46,909,630	$ 5	$ 171	$ 143	$ 14,486	$ 867	$ 1,250
Shares, Outstanding, Ending Balance at Jun. 30, 2021				5	1,714,286	1,428,570	144,828,817	8,673,088	12,500,200

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Net Cash Provided by (Used in) Operating Activities
Net loss	$ (9,256,745)	$ (2,312,526)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities
Depreciation and amortization	1,673,164	1,029,544
Gain on extinguishment of debt	(803,079)	(91,641)
Gain of forgiveness of debt	(589,282)	0
Change in fair value of contingent consideration	0	(500,000)
Change in fair value of derivative liabilities	0	(2,298,609)
Stock issued for penalties	0	44,700
Employee stock compensation	27,329	39,117
Amortization of debt discounts	1,436,052	370,136
Non-cash lease expense	210,025	130,534
Impairment loss of intangible asset and goodwill	0	1,111,600
Change in current assets and liabilities:
Increase (Decrease) in Receivables	(2,037,949)	2,584,318
Increase (Decrease) in Inventories	(2,554,413)	2,356
Capitalized Contract Cost, Amortization	(1,144,546)	16,322
Increase (Decrease) in Prepaid Expense	(389,719)	145,904
Increase (Decrease) in Accounts Payable	(822,645)	(952,505)
Increase (Decrease) in Accrued Liabilities	1,045,814	(371,138)
Increase (Decrease) in Contract with Customer, Liability	(950,176)	247,715
Operating lease liability	(218,087)	(126,302)
Increase (Decrease) in Deferred Revenue	0	(12,509)
Net cash used in operating activities	(14,374,257)	(942,984)
Net Cash Provided by (Used in) Investing Activities
Capital expenditures	(317,958)	(68,182)
Cash paid for acquisitions	(16,824,000)	(2,513,355)
Cash assumed in acquisition	81,442	0
Net cash used in investing activities	(17,060,516)	(2,581,537)
Net Cash Provided by (Used in) Financing Activities
Proceeds from the sale of common stock, net of offering costs	54,302,982	250,000
Proceeds from issuances of notes payable, related parties	0	19,000
Proceeds from issuances of notes payable, non-related party	15,609	4,644,817
Proceeds from issuances of convertible notes payable	408,000	0
Proceeds from financing lease	0	2,000,000
Repurchase of common stock	(185,850)	0
Repayments of notes payable, related party	(130,831)	(207,822)
Repayments of notes payable, non-related parties	(6,992,968)	(1,375,914)
Repayments of convertible notes payable	(1,680,964)	(195,008)
Repayment of line of credit	(2,821,033)	(1,003,477)
Cash paid on financing lease obligations	(345,303)	(213,565)
Net cash provided by financing activities	42,569,642	3,918,031
NET INCREASE IN CASH AND RESTRICTED CASH	11,134,869	393,510
CASH AND RESTRICTED CASH, BEGINNING BALANCE	722,583	302,486
CASH AND RESTRICTED CASH, ENDING BALANCE	11,857,452	695,996
Supplemental Cash Flow Information
Interest Paid	1,099,209	1,985,847
Income Taxes Paid	0	0
Supplemental Cash Flow Elements
Penalty interest added to debt	0	15,000
Common stock issued for convertible note payable and accrued interest	1,529,398	697,332
Common stock issued for debt settlement	0	330,528
Issuance of note payable for acquisition	0	2,300,000
Common stock issued for acquisition	2,535,071	0
Common stock issued to settle unpaid salaries	0	603,463
ROU asset and operating lease obligation recognized under Topic 842	3,689,634	193,541
Remeasurement of finance lease liability	279,287	0
Equipment purchased on financing lease	0	756,990
Other asset reclassified to fixed asset	0	86,471
Issuance of shares of series D preferred stock for acquisition	6,653,309	0
Beneficial conversion feature on convertible notes	$ 92,428	$ 0

Note 1 - Organization and Basis

Note 1 - Organization and Basis of Presentation	6 Months Ended
	Jun. 30, 2021
Notes
Note 1 - Organization and Basis of Presentation	Note 1 – Organization and Basis of Presentation The unaudited consolidated financial statements were prepared by Alpine 4 Holdings, Inc. (‘we,” “our,” or the "Company"), pursuant to the rules and regulations of the Securities Exchange Commission ("SEC"). The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") were omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company's Annual Report on Form 10-K filed with the SEC on April 15, 2021. The results for the six months ended June 30, 2021, are not necessarily indicative of the results to be expected for the year ending December 31, 2021. The Company was incorporated under the laws of the State of Delaware on April 22, 2014. The Company was formed to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock, or other business combination with a domestic or foreign business. On March 2, 2021, the Company changed its name from Alpine 4 Technologies Ltd. to Alpine 4 Holdings, Inc. Effective January 1, 2019, the Company purchased all of the outstanding capital stock of Morris Sheet Metal Corp., an Indiana corporation (“MSM”), JTD Spiral, Inc. a wholly owned subsidiary of MSM, an Indiana corporation, Morris Enterprises LLC, an Indiana limited liability company, and Morris Transportation LLC, an Indiana limited liability company (collectively “Morris”). Effective November 6, 2019, the Company purchased all of the outstanding capital stock and units of Deluxe Sheet Metal, Inc., an Indiana corporation, and DSM Holding, LLC, an Indiana limited liability company, and purchased certain real estate from Lonewolf Enterprises, LLC, an Indiana limited liability company (collectively “Deluxe”). Effective February 21, 2020, the Company purchased all of the outstanding units of Excel Fabrication, LLC., an Idaho limited liability company (“Excel”). Excel subsequently changed its name to Excel Construction Services, LLC. Effective December 15, 2020, the Company purchased the assets of Impossible Aerospace Corporation, a Delaware corporation (“IA”). Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”). On May 5, 2021, the Company acquired all of the outstanding shares of stock of Thermal Dynamics, Inc., a Delaware corporation (“TDI”). On May 10, 2021, the Company acquired all of the outstanding membership interests of KAI Enterprises, LLC, a Florida limited liability company, the sole asset of which was all of the outstanding membership interests of Alternative Laboratories, LLC, a Delaware limited liability company (“Alt Labs”). As of the date of this Report, the Company was a holding company owning, directly or indirectly, eleven companies: · · · · · · · · · · · Basis of presentation The accompanying consolidated financial statements present the balance sheets, statements of operations, stockholders' deficit and cash flows of the Company. The financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Liquidity The Company’s financial statements are prepared in accordance with U.S. GAAP applicable to a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board (the “FASB”), Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. While the Company experienced a loss for the six months ended June 30, 2021, of $9.3 million, and had a negative cash flow used in operations, there were significant non-recurring items related to the RSU purchases totaling approximately $1.8 million contributing to the loss. The Company received a total of approximately $54.0 million in February 2021 in the following two transactions: · · The Company plans to continue to generate additional revenue (and improve cash flows from operations) partly from the acquisitions of two operating companies which closed in May 2021 combined with improved performance from the existing operating companies. Based on the capital raise as indicated above and management’s plans to improve cash flows from operations, management believes the Company has sufficient working capital to satisfy the Company’s estimated liquidity needs for the next 12 months. The Company ended the June 30, 2021, quarter with $10.5 million in cash and $1.4 million in restricted cash after the purchase of the two operating companies in May 2021. As of the date of this Report, the Company had $7.1 million in cash and $1.4 million in restricted cash. During the six months ended June 30, 2021, the Company paid down liabilities of approximately $13.0 million. In addition, approximately $3.0 million was used to build inventory and for capital expenditures. However, there is no assurance that management’s plans will be successful due to the current economic climate in the United States and globally.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Notes
Note 2 - Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Principles of consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of June 30, 2021 and December 31, 2020. Significant intercompany balances and transactions have been eliminated. Use of estimates The consolidated financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond. COVID-19 did have a negative impact on the Company’s financial performance in 2020. During the six months ended June 30, 2021, there was no impairment charge related to intangible assets and goodwill. Cash and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of June 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of June 30, 2021, and December 31, 2020, the Company had $1,400,000 and $444,845 in restricted cash, respectively, for amounts held in escrow. The $1,400,000 held in escrow as of June 30, 2021 was for the purchase of the building located at 4740 Cleveland Ft. Myers, FL, for Alt Labs (see Note 8). The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. June 30, December 31, 2021 2020 Cash $ 10,457,452 $ 277,738 Restricted cash 1,400,000 444,845 Total cash and restricted cash shown in statement of cash flows $ 11,857,452 $ 722,583 Major Customers The Company had two customers that made up 13% and 12%, respectively, of accounts receivable as of June 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020. For the six months ended June 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively Fair value measurements Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 Level 2 Level 3 The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of June 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis. Research and Development The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the six months ended June 30, 2021, research and development cost totaled $515,202. Earnings (loss) per shares The Company presents both basic and diluted net loss per share on the face of the consolidated statements of operations. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and six months ended June 30, 2021 and 2020: For the Three Months Ended June 30, 2021 For the Three Months Ended June 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (3,127,277) 161,712,406 $ (0.02) $ (2,562,914) 131,173,215 $ (0.02) Effect of Dilutive Securities Convertible debt - - - - - - Dilute EPS Net loss plus assumed conversions $ (3,127,277) 161,712,406 $ (0.02) $ (2,562,914) 131,173,215 $ (0.02) For the Six Months Ended June 30, 2021 For the Six Months Ended June 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (9,256,745) 158,184,050 $ (0.06) $ (2,312,526) 129,190,454 $ (0.02) Effect of Dilutive Securities Convertible debt - - - (1,772,619) 9,881,522 - Dilute EPS Net loss plus assumed conversions $ (9,256,745) 158,184,050 $ (0.06) $ (4,085,145) 139,071,976 $ (0.03)

Note 3 - Leases

Note 3 - Leases	6 Months Ended
	Jun. 30, 2021
Notes
Note 3 - Leases	Note 3 – Leases The Company determines whether a contract is or contains a lease at inception of the contract and whether that lease meets the classification criteria of a finance or operating lease. When available, the Company uses the rate implicit in the lease to discount lease payments to present value; however, most of the Company’s leases do not provide a readily determinable implicit rate. Therefore, the Company must discount lease payments based on an estimate of its incremental borrowing rate. As of June 30, 2021, the future minimum finance and operating lease payments were as follows: Finance Operating Twelve Months Ending June 30 , Leases Leases 2022 $ 1,887,487 $ 944,156 2023 1,919,067 804,140 2024 1,938,189 806,172 2025 1,944,185 780,772 2026 1,849,137 700,000 Thereafter 17,705,691 583,333 Total payments 27,243,756 4,618,573 Less: imputed interest (10,983,069) (543,496) Total obligation 16,260,687 4,075,077 Less: current portion (608,301) (763,328) Non-current financing leases obligations $ 15,652,386 $ 3,311,749 As of October 1, 2020, the American Precision Fabricators, Inc. (“APF”) building lease with Harbor Island Properties, LLC was modified, assignment was transferred to Excel Fabrication, LLC (“Excel”), and Quality Circuit Assembly, Inc. (“QCA”). As part of the modification, the lease was extended through 2037 and the payment terms were amended effective January 15, 2021. As a result of this amendment, the Company remeasured the finance lease liability and recorded an additional $279,287 to the related asset and finance lease liability on the date of the modification. Operating Leases The table below presents the lease related assets and liabilities recorded on the Company’s consolidated balance sheets as of June 30, 2021, and December 31, 2020: June 30, December 31, Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ 4,060,920 $ 581,311 Total lease assets $ 4,060,920 $ 581,311 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 763,328 $ 334,500 Noncurrent liabilities Operating lease liability Long-term operating lease liability 3,311,749 269,030 Total lease liability $ 4,075,077 $ 603,530 On May 3, 2021, the Company entered into a lease agreement for the building on 4740 Cleveland in Ft. Myers, Fl. The lease has a term of 72 months with monthly payments ranging from $40,833 to $49,583 from May 2021-July 2021 and $58,333 from August 2021 through the end of the term. The Company determined the lease to be an operating lease and recognized a right-of-use asset and operating lease liability of $3,689,634 based on the present value of the minimum lease payments discounted using an incremental borrowing rate of 3.96%. At June 30, 2021 and December 31, 2020, the weighted average remaining lease terms were 5.49 and 2.98 years; respectively, and the weighted average discount rate were 11% and 15%, respectively.

Note 4 - Notes Payable

Note 4 - Notes Payable	6 Months Ended
	Jun. 30, 2021
Notes
Note 4 - Notes Payable	Note 4 – Notes Payable The outstanding balances for the loans as of June 30, 2021, and December 31, 2020, were as follows: June 30, December 31, 2021 2020 Lines of credit, current portion $ - $ 2,819,793 Equipment loans, current portion 64,120 245,388 PPP loans 4,586,158 - Term notes, current portion 5,412,355 4,035,730 Total current 10,062,633 7,100,911 PPP/EIDL loans 877,083 4,340,956 Long-term portion of equipment loans and term notes 2,069,713 10,860,494 Total notes payable $ 13,009,429 $ 22,302,361 Future scheduled maturities of outstanding notes payable are as follows: Twelve Months Ending June 30, 2022 $ 10,062,633 2023 819,478 2024 2,062,318 2025 - 2026 - Thereafter 65,000 Total $ 13,009,429 During the six months ended June 30, 2021, the Company received forgiveness on four loans under the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act. The Company recognized a gain on forgiveness of debt of $589,282. In connection with the Deluxe acquisition in November 2019, the Company issued two subordinated secured promissory notes to the seller. The first note for $1,900,000 bears interest at 4.25% per annum, require monthly payment for the first 35 months of $19,463 with any remaining principal and accrued interest due on the 3 year-anniversary. The second note for $496,343 bore interest at 8.75% matured in January 2020 and was fully settled through a debt conversion agreement with the seller. On April 8, 2021, the Company entered into a settlement agreement with the seller wherein the outstanding balance on the first note amounting to $1,883,418 including accrued interest and net other costs was settled in full through a payment of approximately $887,000 and the exchange of 1,617,067 shares of the Company’s Class C common shares held by the seller for the same number of shares of the Company’s Class A common stock. The Company recognized a gain on extinguishment of debt totaling $803,079 during the six months ended June 30, 2021 as a result of the settlement of the note.

Note 5 - Notes Payable, Related

Note 5 - Notes Payable, Related Parties	6 Months Ended
	Jun. 30, 2021
Notes
Note 5 - Notes Payable, Related Parties	Note 5 – Notes Payable, Related Parties At June 30, 2021, and December 31, 2020, notes payable due to related parties consisted of the following: June 30, December 31, 2021 2020 Notes payable; non-interest bearing; due upon demand; unsecured $ 3,000 $ 3,000 Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured 104,820 235,651 Total notes payable - related parties $ 107,820 $ 238,651 Two non-interest-bearing notes totaling $3,000 were in default as of June 30, 2021. These notes were due on demand by the lenders as of the date of this Report.

Note 6 - Convertible Notes Paya

Note 6 - Convertible Notes Payable	6 Months Ended
	Jun. 30, 2021
Notes
Note 6 - Convertible Notes Payable	Note 6 – Convertible Notes Payable At June 30, 2021, and December 31, 2020, convertible notes payable consisted of the following: June 30, December 31, 2021 2020 Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017. The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share. $ 7,500 $ 25,000 Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019. On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively. In May and June 2020, these convertible notes were amended -- see (A) below. The outstanding principal and interest balances were fully paid during the six months ended June 30, 2021. - 1,291,463 On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200. The note is due September 7, 2019 and bears interest at 12% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the six months ended June 30, 2021. - 7,538 On November 14, 2019, the Company issued a convertible note for $200,000. The note is due November 13, 2020 and bears interest at 15% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. As of June 30, 2021, this note is past due. 200,000 200,000 In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500. The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. As of June 30, 2021, the remaining note outstanding is past due. 150,000 1,482,500 Total convertible notes payable 357,500 3,006,501 Less: discount on convertible notes payable - (1,343,624) Total convertible notes payable, net of discount 357,500 1,662,877 Less: current portion of convertible notes payable (357,500) (562,242) Long-term portion of convertible notes payable $ - $ 1,100,635 In May and June 2020 the Company amended the following seller notes: - - A loss on extinguishment of debt of $192,272 was recognized on these transactions in June 2020. During the six months ended June 30, 2021, and the year ended December 31, 2020, the Company issued convertible notes with fixed conversion prices. The Company recognized a beneficial conversion feature related to these convertible notes amounting to $92,428 and $1,482,500 for the six months ended June 30, 2021, and the year ended December 31, 2020, respectively, as a debt discount to the convertible notes and as a component of equity. The discounts are being amortized over the terms of the convertible notes payable. Amortization of debt discounts during the six months ended June 30, 2021 and 2020, amounted to $1,436,052 and $370,136, respectively, and is recorded as interest expense in the accompanying consolidated statements of operations. There was no remaining unamortized discount balance for these notes as of June 30, 2021. A summary of the activity in the Company's convertible notes payable is provided below: Balance outstanding, December 31, 2020 $ 1,662,877 Issuance of convertible notes payable for cash 408,000 Repayment of notes (1,680,964) Conversion of notes payable to common stock (1,376,037) Amortization of debt discounts 1,436,052 Discount from beneficial conversion feature (92,428) Balance outstanding, June 30, 2021 $ 357,500

Note 7 - Stockholders' Equity

Note 7 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2021
Notes
Note 7 - Stockholders' Equity	Note 7 – Stockholders' Equity Common Stock The Company had the following transactions in its common stock during the six months ended June 30, 2021: · · · · · · · · Preferred Stock · · Stock Options The following summarizes the stock option activity for the six months ended June 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding at December 31, 2020 1,790,000 $ 0.19 7.09 $ 6,176,855 Granted - Forfeited - Exercised - Outstanding at June 30, 2021 1,790,000 $ 0.19 6.60 $ 5,550,355 Vested and expected to vest at June 30, 2021 1,790,000 $ 0.19 6.60 $ 5,550,355 Exercisable at June 30, 2021 1,405,000 $ 0.22 6.50 $ 4,308,038 The following table summarizes information about options outstanding and exercisable as of June 30, 2021: Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price 0.05 979,000 6.88 0.05 665,500 0.05 0.10 85,000 6.78 0.10 63,750 0.10 0.13 388,500 6.09 0.13 338,250 0.13 0.26 114,000 5.84 0.26 114,000 0.26 0.90 223,500 5.77 0.90 223,500 0.90 1,790,000 1,405,000 During the six months ended June 30, 2021 and 2020, stock option expense amounted to $27,329 and $39,112, respectively. Unrecognized stock option expense as of June 30, 2021, amounted to $16,419, which will be recognized over a period extending through December 2022. Warrants The following summarizes the warrants activity for the six months ended June 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding at December 31, 2020 275,000 $ 1.01 0.23 $ 723,250 Granted 416,667 6.60 Forfeited (275,000) 1.01 Exercised - Outstanding at June 30, 2021 416,667 $ 6.60 3.64 $ - Vested and expected to vest at June 30, 2021 416,667 $ 6.60 3.64 $ - Exercisable at June 30, 2021 - $ - - $ - The following table summarizes information about warrants outstanding and exercisable as of June 30, 2021: Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 6.60 416,667 3.64 $ 6.60 - $ - 416,667 - During the six months ended June 30, 2021, the Company issued 416,667 warrants to a placement agent in connection with sale of its common stock. The warrants have an exercise price of $6.60, become exercisable on August 16, 2021 and expire on February 16, 2025. The fair value of the 416,667 warrants, issued to the placement agent during the six months ended June 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions: Stock price $6.00 Risk-free interest rate 0.01% Expected life of the options 4 years Expected volatility 347% Expected dividend yield 0% The fair value of the warrants was recorded as offering costs with a corresponding credit to additional paid in capital.

Note 8 - Business Combination

Note 8 - Business Combination	6 Months Ended
	Jun. 30, 2021
Notes
Note 8 - Business Combination	Note 8 – Business Combinations Vayu (US) Effective February 8, 2021, the Company purchased the assets of Vayu (US), Inc., a Delaware corporation (“Vayu”). Under the provision of ASC 805, the Company had to determine whether this acquisition was a business combination or an asset (or a group of assets) acquisition. In doing so, the Company determined that the acquisition of Vayu was in fact an asset purchase. Of the consideration given for the Vayu acquisition more than 95% was concentrated in a single asset or a group of assets in Intellectual Property. As such, the Company accounted for this acquisition as an asset acquisition in accordance with ASC 805-10-20. Accordingly, the assets acquired are initially recognized at the consideration paid, which was the fair value of the series D preferred stock issued, including direct acquisition costs, of which there were none. The cost is allocated to the group of assets acquired based on their relative fair values. The assets acquired and liabilities assumed were as follows at the acquisition date: Purchase Allocation Cash $ 81,442 Property and equipment 50,000 Intellectual property 6,981,256 Non-solicitation covenant 90,000 Accrued expenses and other current liabilities (411,539) SBA loan (PPP funds) (137,850) $ 6,653,309 The purchase price was paid as follows: Series D Preferred Stock $ 6,653,309 $ 6,653,309 TDI On May 5, 2021, the Company closed on the acquisition of Thermal Dynamics, Inc., a Delaware corporation. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date. Purchase Allocation Accounts receivable $ 1,408,682 Contract assets 826,231 Property and equipment 111,789 Intangible assets 4,820,000 Goodwill 3,528,621 Accounts payable (786,151) Accrued expenses and other current liabilities (53,857) Contract liability (2,334,188) Notes payable (64,733) $ 7,456,394 The purchase price was paid as follows: Class A Common Stock $ 1,102,394 Cash 6,354,000 $ 7,456,394 Alt Labs On May 10, 2021, the Company closed on the acquisition of Alternative Laboratories, LLC., a Delaware limited liability company. This acquisition was considered an acquisition of a business under ASC 805. A summary of the purchase price allocation at fair value is below. The business combination accounting is not yet complete and the amounts assigned to assets acquired and liabilities assumed are provisional. Therefore, this may result in future adjustments to the provisional amounts as information is obtained about facts and circumstances that existed at the acquisition date. Purchase Allocation Accounts receivable $ 397,441 Inventory 2,621,653 Property and equipment 1,739,441 Intangible assets 10,410,000 Goodwill 252,851 Other asset 390,502 Accounts payable (397,441) Accrued expenses and other current liabilities (62,242) Contract liability (1,754,290) Noted payable (1,695,238) $ 11,902,677 The purchase price was paid as follows: Class A Common Stock $ 1,432,677 Cash 10,470,000 $ 11,902,677 On May 4, 2021, the Company also entered into an agreement to acquire the 100% membership interest in 4740 Cleveland LLC (“Cleveland”), a Florida limited liability company that is the owner of the building currently being leased by Alt Labs, for a total purchase price of $7,000,000. In connection with this agreement, the Company placed in escrow the amount of $1,400,000 which will be applied to the purchase price upon closing. The acquisition is expected to close by the end of August 2021. The following are the unaudited pro forma results of operations for the six months ended June 30, 2021 and 2020, as if Excel, Impossible Aerospace, Inc. (“IA”), Vayu, TDI and Alt Labs had been acquired on January 1, 2020. The pro forma results include estimates and assumptions which management believes are reasonable. However, pro forma results do not include any anticipated cost savings or other effects of the planned integration of these entities, and are not necessarily indicative of the results that would have occurred if the business combination had been in effect on the dates indicated. Pro Forma Combined Financials (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Sales $ 17,373,627 $ 16,477,880 $ 32,067,366 $ 35,078,054 Cost of goods sold 11,777,452 10,998,610 23,079,773 25,069,719 Gross profit 5,596,175 5,479,270 8,987,593 10,008,335 Operating expenses 7,545,036 6,693,374 14,508,183 11,899,041 Loss from operations (1,948,861) (1,214,104) (5,520,590) (1,890,706) Net loss (1,748,773) (2,162,795) (6,374,489) (1,397,730) Net loss per share (0.01) (0.02) (0.04) (0.01)

Note 9 - Industry Segments

Note 9 - Industry Segments	6 Months Ended
	Jun. 30, 2021
Notes
Note 9 - Industry Segments	Note 9 – Industry Segments This summary presents the Company's segments: QCA; APF; Morris Sheet Metal Corp, Morris Enterprises LLC, and Morris Transportation LLC (collectively, “Morris”); Deluxe Sheet Metal, Inc., DSM Holding, LLC (collectively, “DSM”), Excel; IA and Vayu combined; TDI; and Alt Labs for the three and six months ended June 30, 2021, and June 30, 2020, and as of June 30, 2021 and December 31, 2020: Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue QCA $ 4,441,919 $ 2,353,502 $ 8,180,228 $ 4,383,628 APF - 1,256,375 - 1,785,416 Morris 3,442,625 2,516,499 6,572,281 5,771,426 Deluxe 1,422,984 1,509,104 2,300,797 3,903,268 Excel 562,612 1,407,384 1,226,373 2,034,722 TDI 1,145,105 - 1,145,105 - Alt Labs 3,115,485 - 3,115,485 - $ 14,130,730 $ 9,042,864 $ 22,540,269 $ 17,878,460 Gross profit QCA $ 1,252,086 $ 629,684 $ 2,164,363 $ 1,135,466 APF - 200,347 - 170,705 Morris 780,702 550,829 1,127,701 1,180,452 Deluxe 55,372 (104,978) (691,193) 409,217 Excel 35,786 680,134 277,694 819,920 TDI 460,218 - 460,218 - Alt Labs 1,379,896 - 1,379,896 - $ 3,964,060 $ 1,956,016 $ 4,718,679 $ 3,715,760 Income (loss) from operations QCA $ 460,554 $ 148,185 $ 784,385 $ 39,033 APF (39,445) (1,089,485) (109,087) (1,317,929) Morris 164,962 192,197 (102,941) 383,064 Deluxe (448,061) (386,211) (2,114,020) (306,249) Excel (469,632) 478,571 (639,572) 257,611 IA and Vayu (705,398) - (2,923,177) - TDI 3,622 - 3,622 - Alt Labs 56,840 - 56,840 - Unallocated and eliminations (1,927,659) (949,454) (2,932,336) (1,765,372) $ (2,904,217) $ (1,606,197) $ (7,976,286) $ (2,709,842) Depreciation and amortization QCA $ 203,642 $ 67,723 $ 327,587 $ 121,704 APF 38,974 71,960 78,388 143,921 Morris 158,754 173,326 242,571 324,590 Deluxe 182,931 175,111 365,861 351,361 Excel 79,641 57,162 145,616 87,968 IA and Vayu 48,124 - 226,368 - TDI 56,217 - 56,217 - Alt Labs 173,648 - 173,648 - Unallocated and eliminations 8,807 - 56,908 - $ 950,738 $ 545,282 $ 1,673,164 $ 1,029,544 Interest Expense QCA $ 125,959 $ 126,697 $ 264,238 $ 247,142 APF 320 55,067 4,397 135,011 Morris 96,718 210,672 189,430 585,072 Deluxe 142,938 137,085 326,771 394,287 Excel 60,978 129,174 166,269 177,029 TDI 825 - 825 - Alt Labs 240 - 240 - Unallocated and eliminations 788,609 247,147 1,736,140 1,016,528 $ 1,216,587 $ 905,842 $ 2,688,310 $ 2,555,069 Net income (loss) QCA $ 349,578 $ 20,141 $ 514,544 $ (165,549) APF (39,765) (1,015,231) (113,484) (1,380,346) Morris 107,661 (12,015) (247,426) 308,397 Deluxe 229,012 (523,293) (1,620,938) (602,599) Excel (530,610) 349,397 (805,841) 80,582 IA and Vayu (705,407) - (2,493,646) - TDI 6,384 - 6,384 - Alt Labs 56,599 - 56,599 - Unallocated and eliminations (2,600,729) (1,381,913) (4,552,937) (553,011) $ (3,127,277) $ (2,562,914) $ (9,256,745) $ (2,312,526) As of As of June 30, December 31, 2021 2020 Total Assets QCA $ 12,909,816 $ 9,574,237 APF 1,033,430 1,157,699 Morris 9,520,054 6,881,599 Deluxe 10,842,897 12,039,414 Excel 3,762,088 3,727,168 IA and Vayu 14,804,265 6,342,863 TDI 11,047,236 - Alt Labs 20,962,466 - Unallocated and eliminations 9,145,584 1,011,203 $ 94,027,836 $ 40,734,183 Goodwill QCA $ 1,963,761 $ 1,963,761 Morris 113,592 113,592 Excel 7,629 7,629 TDI 3,528,621 - Alt Labs 252,851 - $ 5,866,454 $ 2,084,982 Accounts receivable, net QCA $ 3,477,482 $ 1,938,446 APF 45,022 45,022 Morris 3,066,332 1,944,269 Deluxe 1,060,541 2,015,745 Excel 592,438 541,387 TDI 1,199,925 - Alt Labs 887,201 - $ 10,328,941 $ 6,484,869

Note 10 - Contingencies

Note 10 - Contingencies	6 Months Ended
	Jun. 30, 2021
Notes
Note 10 - Contingencies	Note 10 – Commitments and Contingencies Legal Proceedings From time to time, the Company may become involved in lawsuits and other legal proceedings that arise in the course of business. Litigation is subject to inherent uncertainties, and it is not possible to predict the outcome of litigation with total confidence. As of the date of this Report, the Company was not aware of any legal proceedings or potential claims against it whose outcome would be likely, individually or in the aggregate, to have a material adverse effect on the Company’s business, financial condition, operating results, or cash flows, except as set forth below. In June 2020, the Company’s subsidiary Excel Fabrication, LLC filed a lawsuit against Fusion Mechanical, LLC, in the Fifth Judicial District Court, State of Idaho (Case Number CV42-20-2246). The Company claimed tortious interference and trade secret violations by the defendant. The defendant filed a motion to dismiss, which was denied by the Court. The defendant filed a second motion to dismiss and the Company filed a memorandum in response to the second motion to dismiss, for which a hearing was held on May 10, 2021. On June 11, 2021, the court issued a decision narrowing the claims of the plaintiffs to three items, breach of contract, good faith and fair dealings and intentional interference for economic advantage. These were the Company’s three main points of contention. As of the date of this Report, discovery was proceeding. The Company intends to pursue vigorously its claims. In August 2020, the Company filed a lawsuit, in the United States District Court, District of Arizona (Case No.2:20-cv-01679-DJH), against Alan Martin, the seller of Horizon Well Testing LLC (“HWT”) dba Venture West Energy Services, LLC. The Company brought claims for breach of contract, including but not limited to breaches of the seller’s representations and warranties in the purchase agreement in connection with the acquisition of HWT. The defendant answered and counterclaimed, claiming breach by the Company of its obligation to issue a promissory note (to be issued in connection with the acquisition of HWT). The parties have engaged in discovery and settlement negotiations, both of which are ongoing. In May 2021, the Company and several shareholders filed a lawsuit, in the United States District Court for the District of Arizona (Case number 2:21-cv-00886-MTL) against Fin Capital LLC ("Fin Cap"), and Grizzly Research LLC ("Grizzly") alleging securities fraud, tortious interference with business expectancy and libel and slander for disseminating false and misleading statements about Alpine 4 and its employees to manipulate the stock price and further their own financial interests.

Note 11 - Subsequent Events

Note 11 - Subsequent Events	6 Months Ended
	Jun. 30, 2021
Notes
Note 11 - Subsequent Events	Note 11 – Subsequent Events In July and August 2021, the Company received notices from the Small Business Administration that the PPP loans with principal amounts and related interest totaling to $4,287,291 and $72,741, respectively, were forgiven. On July 7, 2021, the Company issued 52,500 shares of Class A common stock upon the conversion of convertible notes totaling $150,000.

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Principles of Consolidation	Principles of consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries as of June 30, 2021 and December 31, 2020. Significant intercompany balances and transactions have been eliminated.

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies: Use of Estimates, Policy (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Use of Estimates, Policy	Use of estimates The consolidated financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. In many instances, the Company could have reasonably used different accounting estimates and in other instances changes in the accounting estimates are reasonably likely to occur from period to period. This applies in particular to useful lives of long-lived assets, valuation allowance for deferred tax assets and impairment of long-lived assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2021 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, and the speed with which the economy recovers. The Company is not able to fully quantify the impact that these factors will have on the Company’s financial results during 2021 and beyond. COVID-19 did have a negative impact on the Company’s financial performance in 2020. During the six months ended June 30, 2021, there was no impairment charge related to intangible assets and goodwill.

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Cash and Restricted Cash	Cash and Restricted Cash Cash and cash equivalents consist of cash and short-term investments with original maturities of less than 90 days. As of June 30, 2021, and December 31, 2020, the Company had no cash equivalents. As of June 30, 2021, and December 31, 2020, the Company had $1,400,000 and $444,845 in restricted cash, respectively, for amounts held in escrow. The $1,400,000 held in escrow as of June 30, 2021 was for the purchase of the building located at 4740 Cleveland Ft. Myers, FL, for Alt Labs (see Note 8). The following table sets forth a reconciliation of cash, and restricted cash reported in the consolidated statements of cash flows that agrees to the total of those amounts presented in the consolidated statements of cash flows. June 30, December 31, 2021 2020 Cash $ 10,457,452 $ 277,738 Restricted cash 1,400,000 444,845 Total cash and restricted cash shown in statement of cash flows $ 11,857,452 $ 722,583

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies: Major Customers (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Major Customers	Major Customers The Company had two customers that made up 13% and 12%, respectively, of accounts receivable as of June 30, 2021. The Company had two customers that made up 10% and 8%, respectively, of accounts receivable as of December 31, 2020. For the six months ended June 30, 2021 and 2020, the Company had one customer that made up 13% and 10% of total revenues, respectively

Note 2 - Summary of Significa_6

Note 2 - Summary of Significant Accounting Policies: Fair Value Measurement (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Fair Value Measurement	Fair value measurements Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 Level 2 Level 3 The Company's financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, convertible notes, notes payable and lines of credit. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. As of June 30, 2021 and December 31, 2020, the Company had no financial assets or liabilities that were required to be fair valued on a recurring basis. Research and Development The Company focuses on quality control and development of new products and the improvement of existing products. All cost related to research and development activities are expensed as incurred. During the six months ended June 30, 2021, research and development cost totaled $515,202.

Note 2 - Summary of Significa_7

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share (Policies)	6 Months Ended
	Jun. 30, 2021
Policies
Earnings (loss) per share	Earnings (loss) per shares The Company presents both basic and diluted net loss per share on the face of the consolidated statements of operations. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted per share calculations give effect to all potentially dilutive shares of common stock outstanding during the period, including stock options and warrants, and using the treasury-stock method. If antidilutive, the effect of potentially dilutive shares of common stock is ignored. The only potentially dilutive securities outstanding during the periods presented were the convertible debt, options and warrants. The following table illustrates the computation of basic and diluted earnings per share (“EPS”) for the three and six months ended June 30, 2021 and 2020: For the Three Months Ended June 30, 2021 For the Three Months Ended June 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (3,127,277) 161,712,406 $ (0.02) $ (2,562,914) 131,173,215 $ (0.02) Effect of Dilutive Securities Convertible debt - - - - - - Dilute EPS Net loss plus assumed conversions $ (3,127,277) 161,712,406 $ (0.02) $ (2,562,914) 131,173,215 $ (0.02) For the Six Months Ended June 30, 2021 For the Six Months Ended June 30, 2020 Net loss Shares Per Share Amount Net loss Shares Per Share Amount Basic EPS Net loss $ (9,256,745) 158,184,050 $ (0.06) $ (2,312,526) 129,190,454 $ (0.02) Effect of Dilutive Securities Convertible debt - - - (1,772,619) 9,881,522 - Dilute EPS Net loss plus assumed conversions $ (9,256,745) 158,184,050 $ (0.06) $ (4,085,145) 139,071,976 $ (0.03)

Note 2 - Summary of Significa_8

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table	June 30, December 31, 2021 2020 Cash $ 10,457,452 $ 277,738 Restricted cash 1,400,000 444,845 Total cash and restricted cash shown in statement of cash flows $ 11,857,452 $ 722,583

Note 3 - Leases_ Schedule of Fu

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Future Minimum Lease Payments for Capital Leases	Finance Operating Twelve Months Ending June 30 , Leases Leases 2022 $ 1,887,487 $ 944,156 2023 1,919,067 804,140 2024 1,938,189 806,172 2025 1,944,185 780,772 2026 1,849,137 700,000 Thereafter 17,705,691 583,333 Total payments 27,243,756 4,618,573 Less: imputed interest (10,983,069) (543,496) Total obligation 16,260,687 4,075,077 Less: current portion (608,301) (763,328) Non-current financing leases obligations $ 15,652,386 $ 3,311,749

Note 3 - Leases_ Schedule of Ri

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Right of Use Assets and Lease Liabilities	June 30, December 31, Classification on Balance Sheet 2021 2020 Assets Operating lease assets Operating lease right of use assets $ 4,060,920 $ 581,311 Total lease assets $ 4,060,920 $ 581,311 Liabilities Current liabilities Operating lease liability Current operating lease liability $ 763,328 $ 334,500 Noncurrent liabilities Operating lease liability Long-term operating lease liability 3,311,749 269,030 Total lease liability $ 4,075,077 $ 603,530

Note 4 - Notes Payable_ Schedul

Note 4 - Notes Payable: Schedule of Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Notes Payable	June 30, December 31, 2021 2020 Lines of credit, current portion $ - $ 2,819,793 Equipment loans, current portion 64,120 245,388 PPP loans 4,586,158 - Term notes, current portion 5,412,355 4,035,730 Total current 10,062,633 7,100,911 PPP/EIDL loans 877,083 4,340,956 Long-term portion of equipment loans and term notes 2,069,713 10,860,494 Total notes payable $ 13,009,429 $ 22,302,361

Note 5 - Notes Payable, Relat_2

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Notes Payable, Related Parties	June 30, December 31, 2021 2020 Notes payable; non-interest bearing; due upon demand; unsecured $ 3,000 $ 3,000 Series of notes payable, bearing interest at rates from 0% to 20% per annum, with maturity dates from April 2018 to July 2021, unsecured 104,820 235,651 Total notes payable - related parties $ 107,820 $ 238,651

Note 6 - Convertible Notes Pa_2

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Convertible Notes Payable	June 30, December 31, 2021 2020 Series of convertible notes payable issued prior to December 31, 2016, bearing interest at rates of 8% - 10% per annum, with due dates ranging from December 2016 through June 2017. The outstanding principal and interest balances are convertible into shares of Class A common stock at the option of the debt holder at exercise price of $1 per share. $ 7,500 $ 25,000 Secured convertible notes payable issued to the sellers of QCA on April 1, 2016 for an aggregate of $2,000,000, bearing interest at 5% per annum, due in monthly payments starting on July 1, 2016 and due in full on July 1, 2019. On August 6 and 11, 2019, the Company extended the due date of the two notes to December 31, 2020 and December 31, 2022, respectively. In May and June 2020, these convertible notes were amended -- see (A) below. The outstanding principal and interest balances were fully paid during the six months ended June 30, 2021. - 1,291,463 On December 7, 2018, the Company entered into a variable convertible note for $130,000 with net proceeds of $122,200. The note is due September 7, 2019 and bears interest at 12% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a discount of 40% to the lowest trading closing prices of the stock for 20 days prior to conversion. This note was amended in November 2019 to increase the principal amount by $180,000 due to penalty interest; increase the interest rate to 15% and effect a floor in the conversion price of $0.15 per share. The outstanding principal and interest balance of the note was converted during the six months ended June 30, 2021. - 7,538 On November 14, 2019, the Company issued a convertible note for $200,000. The note is due November 13, 2020 and bears interest at 15% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a fixed price of $0.15 per share. As of June 30, 2021, this note is past due. 200,000 200,000 In December 2020 and January 2021, the Company issued convertible notes to individual investors totaling to $1,890,500. The notes are due three to six months from the date of issuance; accrue interest at 5 – 6.25% per annum and are convertible into shares of the Company's Class A common stock at a fixed rate of $0.25 to $3.00. As of June 30, 2021, the remaining note outstanding is past due. 150,000 1,482,500 Total convertible notes payable 357,500 3,006,501 Less: discount on convertible notes payable - (1,343,624) Total convertible notes payable, net of discount 357,500 1,662,877 Less: current portion of convertible notes payable (357,500) (562,242) Long-term portion of convertible notes payable $ - $ 1,100,635

Note 6 - Convertible Notes Pa_3

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Acitivity of Convertible Notes Payable	Balance outstanding, December 31, 2020 $ 1,662,877 Issuance of convertible notes payable for cash 408,000 Repayment of notes (1,680,964) Conversion of notes payable to common stock (1,376,037) Amortization of debt discounts 1,436,052 Discount from beneficial conversion feature (92,428) Balance outstanding, June 30, 2021 $ 357,500

Note 7 - Stockholders' Equity_

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Common Stock Outstanding Roll Forward	Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding at December 31, 2020 1,790,000 $ 0.19 7.09 $ 6,176,855 Granted - Forfeited - Exercised - Outstanding at June 30, 2021 1,790,000 $ 0.19 6.60 $ 5,550,355 Vested and expected to vest at June 30, 2021 1,790,000 $ 0.19 6.60 $ 5,550,355 Exercisable at June 30, 2021 1,405,000 $ 0.22 6.50 $ 4,308,038 The following table summarizes information about options outstanding and exercisable as of June 30, 2021: Options Outstanding Options Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price 0.05 979,000 6.88 0.05 665,500 0.05 0.10 85,000 6.78 0.10 63,750 0.10 0.13 388,500 6.09 0.13 338,250 0.13 0.26 114,000 5.84 0.26 114,000 0.26 0.90 223,500 5.77 0.90 223,500 0.90 1,790,000 1,405,000

Note 7 - Stockholders' Equity_2

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Stockholders' Equity Note, Warrants or Rights	The following summarizes the warrants activity for the six months ended June 30, 2021: Weighted- Weighted- Average Average Remaining Aggregate Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding at December 31, 2020 275,000 $ 1.01 0.23 $ 723,250 Granted 416,667 6.60 Forfeited (275,000) 1.01 Exercised - Outstanding at June 30, 2021 416,667 $ 6.60 3.64 $ - Vested and expected to vest at June 30, 2021 416,667 $ 6.60 3.64 $ - Exercisable at June 30, 2021 - $ - - $ -

Note 7 - Stockholders' Equity_3

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule Of Summary Of Warrants Outstanding And Exercisable	The following table summarizes information about warrants outstanding and exercisable as of June 30, 2021: Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Average Average Average Exercise Number Remaining Exercise Number Exercise Price of Shares Life (Years) Price of Shares Price $ 6.60 416,667 3.64 $ 6.60 - $ - 416,667 -

Note 7 - Stockholders' Equity_4

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value of the 416,667 warrants, issued to the placement agent during the six months ended June 30, 2021, of $2,498,637 was determined using the Black-Scholes option pricing model with the following assumptions: Stock price $6.00 Risk-free interest rate 0.01% Expected life of the options 4 years Expected volatility 347% Expected dividend yield 0%

Note 8 - Business Combination_

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Tables)	6 Months Ended
	Jun. 30, 2021
Vayu US
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Cash $ 81,442 Property and equipment 50,000 Intellectual property 6,981,256 Non-solicitation covenant 90,000 Accrued expenses and other current liabilities (411,539) SBA loan (PPP funds) (137,850) $ 6,653,309 The purchase price was paid as follows: Series D Preferred Stock $ 6,653,309 $ 6,653,309
TDI
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Accounts receivable $ 1,408,682 Contract assets 826,231 Property and equipment 111,789 Intangible assets 4,820,000 Goodwill 3,528,621 Accounts payable (786,151) Accrued expenses and other current liabilities (53,857) Contract liability (2,334,188) Notes payable (64,733) $ 7,456,394 The purchase price was paid as follows: Class A Common Stock $ 1,102,394 Cash 6,354,000 $ 7,456,394
Alt Labs
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Purchase Allocation Accounts receivable $ 397,441 Inventory 2,621,653 Property and equipment 1,739,441 Intangible assets 10,410,000 Goodwill 252,851 Other asset 390,502 Accounts payable (397,441) Accrued expenses and other current liabilities (62,242) Contract liability (1,754,290) Noted payable (1,695,238) $ 11,902,677 The purchase price was paid as follows: Class A Common Stock $ 1,432,677 Cash 10,470,000 $ 11,902,677

Note 8 - Business Combination_2

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Business Acquisition, Pro Forma Information	Pro Forma Combined Financials (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Sales $ 17,373,627 $ 16,477,880 $ 32,067,366 $ 35,078,054 Cost of goods sold 11,777,452 10,998,610 23,079,773 25,069,719 Gross profit 5,596,175 5,479,270 8,987,593 10,008,335 Operating expenses 7,545,036 6,693,374 14,508,183 11,899,041 Loss from operations (1,948,861) (1,214,104) (5,520,590) (1,890,706) Net loss (1,748,773) (2,162,795) (6,374,489) (1,397,730) Net loss per share (0.01) (0.02) (0.04) (0.01)

Note 9 - Industry Segments_ Sch

Note 9 - Industry Segments: Schedule of Segment Reporting Information, by Segment (Tables)	6 Months Ended
	Jun. 30, 2021
Tables/Schedules
Schedule of Segment Reporting Information, by Segment	Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenue QCA $ 4,441,919 $ 2,353,502 $ 8,180,228 $ 4,383,628 APF - 1,256,375 - 1,785,416 Morris 3,442,625 2,516,499 6,572,281 5,771,426 Deluxe 1,422,984 1,509,104 2,300,797 3,903,268 Excel 562,612 1,407,384 1,226,373 2,034,722 TDI 1,145,105 - 1,145,105 - Alt Labs 3,115,485 - 3,115,485 - $ 14,130,730 $ 9,042,864 $ 22,540,269 $ 17,878,460 Gross profit QCA $ 1,252,086 $ 629,684 $ 2,164,363 $ 1,135,466 APF - 200,347 - 170,705 Morris 780,702 550,829 1,127,701 1,180,452 Deluxe 55,372 (104,978) (691,193) 409,217 Excel 35,786 680,134 277,694 819,920 TDI 460,218 - 460,218 - Alt Labs 1,379,896 - 1,379,896 - $ 3,964,060 $ 1,956,016 $ 4,718,679 $ 3,715,760 Income (loss) from operations QCA $ 460,554 $ 148,185 $ 784,385 $ 39,033 APF (39,445) (1,089,485) (109,087) (1,317,929) Morris 164,962 192,197 (102,941) 383,064 Deluxe (448,061) (386,211) (2,114,020) (306,249) Excel (469,632) 478,571 (639,572) 257,611 IA and Vayu (705,398) - (2,923,177) - TDI 3,622 - 3,622 - Alt Labs 56,840 - 56,840 - Unallocated and eliminations (1,927,659) (949,454) (2,932,336) (1,765,372) $ (2,904,217) $ (1,606,197) $ (7,976,286) $ (2,709,842) Depreciation and amortization QCA $ 203,642 $ 67,723 $ 327,587 $ 121,704 APF 38,974 71,960 78,388 143,921 Morris 158,754 173,326 242,571 324,590 Deluxe 182,931 175,111 365,861 351,361 Excel 79,641 57,162 145,616 87,968 IA and Vayu 48,124 - 226,368 - TDI 56,217 - 56,217 - Alt Labs 173,648 - 173,648 - Unallocated and eliminations 8,807 - 56,908 - $ 950,738 $ 545,282 $ 1,673,164 $ 1,029,544 Interest Expense QCA $ 125,959 $ 126,697 $ 264,238 $ 247,142 APF 320 55,067 4,397 135,011 Morris 96,718 210,672 189,430 585,072 Deluxe 142,938 137,085 326,771 394,287 Excel 60,978 129,174 166,269 177,029 TDI 825 - 825 - Alt Labs 240 - 240 - Unallocated and eliminations 788,609 247,147 1,736,140 1,016,528 $ 1,216,587 $ 905,842 $ 2,688,310 $ 2,555,069 Net income (loss) QCA $ 349,578 $ 20,141 $ 514,544 $ (165,549) APF (39,765) (1,015,231) (113,484) (1,380,346) Morris 107,661 (12,015) (247,426) 308,397 Deluxe 229,012 (523,293) (1,620,938) (602,599) Excel (530,610) 349,397 (805,841) 80,582 IA and Vayu (705,407) - (2,493,646) - TDI 6,384 - 6,384 - Alt Labs 56,599 - 56,599 - Unallocated and eliminations (2,600,729) (1,381,913) (4,552,937) (553,011) $ (3,127,277) $ (2,562,914) $ (9,256,745) $ (2,312,526) As of As of June 30, December 31, 2021 2020 Total Assets QCA $ 12,909,816 $ 9,574,237 APF 1,033,430 1,157,699 Morris 9,520,054 6,881,599 Deluxe 10,842,897 12,039,414 Excel 3,762,088 3,727,168 IA and Vayu 14,804,265 6,342,863 TDI 11,047,236 - Alt Labs 20,962,466 - Unallocated and eliminations 9,145,584 1,011,203 $ 94,027,836 $ 40,734,183 Goodwill QCA $ 1,963,761 $ 1,963,761 Morris 113,592 113,592 Excel 7,629 7,629 TDI 3,528,621 - Alt Labs 252,851 - $ 5,866,454 $ 2,084,982 Accounts receivable, net QCA $ 3,477,482 $ 1,938,446 APF 45,022 45,022 Morris 3,066,332 1,944,269 Deluxe 1,060,541 2,015,745 Excel 592,438 541,387 TDI 1,199,925 - Alt Labs 887,201 - $ 10,328,941 $ 6,484,869

Note 2 - Summary of Significa_9

Note 2 - Summary of Significant Accounting Policies: Cash and Restricted Cash: Schedule Of Reconciliation Of Cash Cash Equivalents And Restricted Cash Table (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Details
Cash	$ 10,457,452	$ 277,738
Restricted Cash	1,400,000	444,845
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 11,857,452	$ 722,583

Note 2 - Summary of Signific_10

Note 2 - Summary of Significant Accounting Policies: Major Customers (Details)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Accounts Receivable Concentration Risk
Concentration Risk, Customer	The Company had two customers that made up 13% and 12%, respectively, of accounts receivable	The Company had two customers that made up 10% and 8%, respectively, of accounts receivable
Revenues Concentration Risk
Concentration Risk, Customer	the Company had one customer that made up 13% and 10% of total revenues, respectively

Note 2 - Summary of Signific_11

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) per share (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Net loss	$ (3,127,277)	$ (6,129,468)	$ (2,562,914)	$ 250,388	$ (9,256,745)	$ (2,312,526)
Weighted Average Number of Shares Outstanding, Basic	161,712,406		131,173,215		158,184,050	129,190,454
Earnings Per Share, Basic	$ (0.02)		$ (0.02)		$ (0.06)	$ (0.02)
Net Income (Loss) Attributable to Parent, Diluted	$ (3,127,277)		$ (2,562,914)		$ (9,256,745)	$ (4,085,145)
Weighted Average Number of Shares Outstanding, Diluted	161,712,406		131,173,215		158,184,050	139,071,976
Earnings Per Share, Diluted	$ (0.02)		$ (0.02)		$ (0.06)	$ (0.03)
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities						$ (1,772,619)
Dilutive Securities, Effect on Basic Earnings Per Share						$ 9,881,522

Note 3 - Leases_ Schedule of _2

Note 3 - Leases: Schedule of Future Minimum Lease Payments for Capital Leases (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Finance Lease, Liability, to be Paid, Year One	$ 1,887,487
Lessee, Operating Lease, Liability, to be Paid, Year One	944,156
Finance Lease, Liability, to be Paid, Year Two	1,919,067
Lessee, Operating Lease, Liability, to be Paid, Year Two	804,140
Finance Lease, Liability, to be Paid, Year Three	1,938,189
Lessee, Operating Lease, Liability, to be Paid, Year Three	806,172
Finance Lease, Liability, to be Paid, Year Four	1,944,185
Lessee, Operating Lease, Liability, to be Paid, Year Four	780,772
Finance Lease, Liability, to be Paid, Year Five	1,849,137
Lessee, Operating Lease, Liability, to be Paid, Year Five	700,000
Finance Lease, Liability, to be Paid, after Year Five	17,705,691
Lessee, Operating Lease, Liability, to be Paid, after Year Five	583,333
Finance Lease, Liability, Payment, Due	27,243,756
Lessee, Operating Lease, Liability, to be Paid	4,618,573
Finance Lease, Liability	16,260,687
Operating Lease, Liability	4,075,077	$ 603,530
Financing lease obligation, current portion	(608,301)	(639,527)
Operating lease obligation, current portion	(763,328)	(334,500)
Financing lease obligations, net of current portion	15,652,386	15,687,176
Operating lease obligations, net of current portion	3,311,749	$ 269,030
Finance Leases
Imputed Interest on Capital Lease	(10,983,069)
Operating Leases
Imputed Interest on Capital Lease	$ (543,496)

Note 3 - Leases_ Schedule of _3

Note 3 - Leases: Schedule of Right of Use Assets and Lease Liabilities (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Details
Right of use assets, net	$ 4,060,920	$ 581,311
Operating lease obligation, current portion	763,328	334,500
Operating lease obligations, net of current portion	3,311,749	269,030
Operating Lease, Liability	$ 4,075,077	$ 603,530

Note 4 - Notes Payable_ Sched_2

Note 4 - Notes Payable: Schedule of Notes Payable (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Notes payable, current portion	$ 10,062,633	$ 7,100,911
Notes Payable	13,009,429	22,302,361
Lines of Credit
Notes payable, current portion	0	2,819,793
Equipment Loans
Notes payable, current portion	64,120	245,388
PPP/EIDL Loans
Notes payable, current portion	4,586,158	0
Long-term Debt	877,083	4,340,956
Short Term Notes
Notes payable, current portion	5,412,355	4,035,730
Equipment, Noncurrent
Long-term Debt	$ 2,069,713	$ 10,860,494

Note 4 - Notes Payable (Details

Note 4 - Notes Payable (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
Details
Future Maturities of Outstanding Notes Payable, Third Parties, Remainder of Current Year	$ 10,062,633
Future Maturities of Outstanding Notes Payable, Third Parties, Year Two	819,478
Future Maturities of Outstanding Notes Payable, Third Parties, Year Three	2,062,318
Future Maturities of Outstanding Notes Payable, Third Parties, Year Four	0
Future Maturities of Outstanding Notes Payable, Third Parties, Year Five	0
Future Maturities of Outstanding Notes Payable, Third Parties, Thereafter	65,000
Future Maturities of Outstanding Notes Payable, Third Parties	$ 13,009,429

Note 5 - Notes Payable, Relat_3

Note 5 - Notes Payable, Related Parties: Schedule of Notes Payable, Related Parties (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Notes payable, related parties	$ 107,820	$ 238,651
Notes Payable 1
Notes payable, related parties	3,000	3,000
Notes Payable 2
Notes payable, related parties	$ 104,820	$ 235,651

Note 6 - Convertible Notes Pa_4

Note 6 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Convertible Notes Payable	$ 357,500	$ 3,006,501
Debt Instrument, Unamortized Discount	0	(1,343,624)
Convertible Notes Payable, net of discount	357,500	1,662,877
Convertible notes payable, current	(357,500)	(562,242)
Convertible notes payable, net of current portion	0	1,100,635
Convertible Notes Payable 1
Convertible Notes Payable	7,500	25,000
Convertible Notes Payable 2
Convertible Notes Payable	0	1,291,463
Convertible Notes Payable 3
Convertible Notes Payable	0	7,538
Convertible Notes Payable 4
Convertible Notes Payable	200,000	200,000
Convertible Notes Payable 5
Convertible Notes Payable	$ 150,000	$ 1,482,500

Note 6 - Convertible Notes Pa_5

Note 6 - Convertible Notes Payable (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Gain (Loss) on Extinguishment of Debt	$ 803,079	$ 91,641
Debt Instrument, Convertible, Beneficial Conversion Feature	92,428	1,482,500
Amortization of debt discounts	$ 1,436,052	$ 370,136
Jeff Moss
Debt Conversion, Converted Instrument, Expiration or Due Date	May 4, 2027
Debt Instrument, Interest Rate During Period	5.00%
Debt Instrument, Periodic Payment	$ 2,605
Debt Instrument, Face Amount	$ 735,329
Dwight Hargreaves
Debt Conversion, Converted Instrument, Expiration or Due Date	Jun. 5, 2026
Debt Instrument, Interest Rate During Period	6.00%
Debt Instrument, Periodic Payment	$ 2,316
Debt Instrument, Face Amount	551,001
Gain (Loss) on Extinguishment of Debt	$ 192,272

Note 6 - Convertible Notes Pa_6

Note 6 - Convertible Notes Payable: Schedule of Acitivity of Convertible Notes Payable (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Details
Convertible Notes Payable, net of discount	$ 357,500		$ 1,662,877
Issuance of convertible notes payable for cash	408,000
Repayments of convertible notes payable	(1,680,964)	$ (195,008)
Conversion of notes payable to common stock	(1,376,037)
Amortization of debt discounts	1,436,052	$ 370,136
Discount from beneficial conversion feature	$ (92,428)

Note 7 - Stockholders' Equity (

Note 7 - Stockholders' Equity (Details) - USD ($)	Feb. 11, 2021	Jun. 30, 2021	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020
Proceeds from the sale of common stock, net of offering costs					$ 54,302,982	$ 250,000
Stock Issued During Period, Value, New Issues				$ 250,000
Stock Issued During Period, Value, Acquisitions		$ 2,535,071	$ 6,653,309
Stock price		$ 6			$ 6
Restricted Stock Units (RSUs)
Stock Repurchased During Period, Shares					514,286
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					$ 7,456,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					11,902,677
Vayu US
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					$ 6,653,309
Common Class A
Stock Issued During Period, Shares, New Issues				3,941,753
Stock Issued During Period, Value, New Issues				$ 394
Stock Issued During Period, Shares, Acquisitions		643,010
Conversion of Class C to Class A, Shares		1,617,067
Conversion of Class C to Class A, Shares		(1,617,067)
Conversion of Class B to Class A, Shares		350,000
Conversion of Class B to Class A, Shares		(350,000)
Stock Issued During Period, Value, Acquisitions		$ 64	0
Common Class A | TDI
Stock Issued During Period, Shares, Acquisitions					281,223
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					$ 1,102,394
Common Class A | Alt Labs
Stock Issued During Period, Shares, Acquisitions					361,787
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					$ 1,432,677
Common Class A | Investor
Stock Issued During Period, Shares, New Issues					1,524,064
Stock Issued During Period, Value, New Issues					$ 9,300,000
Stock Issued During Period, Shares, Conversion of Convertible Securities					5,998,185
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments					$ 1,529,398
Common Class C
Stock Issued During Period, Value, New Issues				0
Conversion of Class C to Class A, Shares		(1,617,067)
Conversion of Class C to Class A, Shares		1,617,067
Stock Issued During Period, Value, Acquisitions		$ 0	0
Common Class C | Investor
Stock Repurchased During Period, Shares					45,000
Stock Repurchased During Period, Value					$ 185,850
Common Class B
Stock Issued During Period, Value, New Issues				0
Conversion of Class B to Class A, Shares		(350,000)
Conversion of Class B to Class A, Shares		350,000
Stock Issued During Period, Value, Acquisitions		$ 0	$ 0
Series D Preferred Stock
Stock Issued During Period, Value, New Issues				0
Stock Issued During Period, Shares, Acquisitions			1,428,570
Stock Issued During Period, Value, Acquisitions		$ 0	$ 143
Series D Preferred Stock | Vayu US
Stock Repurchased During Period, Shares					200,000
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income					$ 6,653,309
Stock price		$ 3.50			$ 3.50
Series C Preferred Stock
Stock Issued During Period, Value, New Issues				$ 0
Stock Issued During Period, Value, Acquisitions		$ 0	$ 0
Series C Preferred Stock | Vayu US
Stock Repurchased During Period, Shares					314,286
Purchase Agreement
Sale of stock	8,333,333
Proceeds from the sale of common stock, net of offering costs	$ 45,000,000

Note 7 - Stockholders' Equity_5

Note 7 - Stockholders' Equity: Schedule of Common Stock Outstanding Roll Forward (Details) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000
Exercisable	1,405,000
Equity Option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	1,790,000		1,790,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.19		$ 0.19
Weighted Average Remaining Contractual Term, Outstanding	6 years 7 months 6 days	7 years 1 month 2 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	0
Forfeited	0
Outstanding, Intrinsic Value	$ 5,550,355
Vested and expected to vest	1,790,000
Weighted average price per share - Vested and Expected to Vest	$ 0.19
Weighted Average Remaining Contractual Term, Vested and Expected to Vest	6 years 7 months 6 days
Outstanding, Intrinsic Value, Vested and Expected to Vest	$ 5,550,355
Exercisable	1,405,000
Weighted average price per share - Exercisable	$ 0.22
Outstanding, Intrinsic Value, Exercisable	$ 4,308,038
Stock Option 1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	979,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.05
Weighted Average Remaining Contractual Term, Outstanding	6 years 10 months 17 days
Exercisable	665,500
Weighted average price per share - Exercisable	$ 0.05
Stock Option 2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	85,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.10
Weighted Average Remaining Contractual Term, Outstanding	6 years 9 months 10 days
Exercisable	63,750
Weighted average price per share - Exercisable	$ 0.10
Stock Option 3
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	388,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.13
Weighted Average Remaining Contractual Term, Outstanding	6 years 1 month 2 days
Exercisable	338,250
Weighted average price per share - Exercisable	$ 0.13
Stock Option 4
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	114,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.26
Weighted Average Remaining Contractual Term, Outstanding	5 years 10 months 2 days
Exercisable	114,000
Weighted average price per share - Exercisable	$ 0.26
Stock Option 5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	223,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.90
Weighted Average Remaining Contractual Term, Outstanding	5 years 9 months 7 days
Exercisable	223,500
Weighted average price per share - Exercisable	$ 0.90

Note 7 - Stockholders' Equity_6

Note 7 - Stockholders' Equity: Schedule of Stockholders' Equity Note, Warrants or Rights (Details) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Outstanding		1,790,000
Exercisable		1,405,000
Warrant
Outstanding	275,000	275,000
Weighted average price per share	$ 1.01	$ 1.01
Weighted Average Remaining Contractual Term, Outstanding	3 years 7 months 20 days		2 months 23 days
Outstanding, Intrinsic Value	$ 0		$ 723,250
Granted		416,667
Weighted average price per share - Granted		$ 6.60
Forfeited		(275,000)
Weighted average price per share - Forfeited		$ 1.01
Exercised		0
Outstanding		416,667	275,000
Weighted average price per share		$ 6.60	$ 1.01
Vested and expected to vest		416,667
Weighted average price per share - Vested and Expected to Vest		$ 6.60
Weighted Average Remaining Contractual Term, Vested and Expected to Vest		3 years 7 months 20 days
Outstanding, Intrinsic Value, Vested and Expected to Vest		$ 0
Exercisable		0
Weighted average price per share - Exercisable		$ 0
Outstanding, Intrinsic Value, Exercisable		$ 0

Note 7 - Stockholders' Equity_7

Note 7 - Stockholders' Equity: Schedule Of Summary Of Warrants Outstanding And Exercisable (Details)	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	0
Warrant 2
Outstanding, Intrinsic Value, Exercisable	416,667
Warrants Exercisable	3 years 7 months 20 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares	$ 6.60
Warrants Exercisable	0
Warrants Exercisable, Weighted Average Exercise Price | $ / shares	$ 0

Note 7 - Stockholders' Equity_8

Note 7 - Stockholders' Equity: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	6 Months Ended
	Jun. 30, 2021$ / shares
Details
Stock price	$ 6
Risk-free interest rate	0.01%
Expected life of the options	4 years
Expected volatility	347.00%
Expected dividend yield	0.00%

Note 8 - Business Combination_3

Note 8 - Business Combination: Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details)	6 Months Ended
	Jun. 30, 2021USD ($)
Vayu US
Cash	$ 81,442
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment	50,000
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Intellectual Property	6,981,256
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Non-Solicitation Covenant	90,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other	(411,539)
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Loan	(137,850)
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
Cash	(81,442)
Vayu US | Series D Preferred Stock
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,653,309
TDI
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	7,456,394
TDI | Business Acquisition, Accounts Receivable
Cash	1,408,682
Cash	(1,408,682)
TDI | Business Acquisition, Contract Asset
Cash	826,231
Cash	(826,231)
TDI | Business Acquisition, Property and Equipment
Cash	111,789
Cash	(111,789)
TDI | Business Acquisition Intangible Assets
Cash	4,820,000
Cash	(4,820,000)
TDI | Business Acquisition, Goodwill
Cash	3,528,621
Cash	(3,528,621)
TDI | Business Acquisition, Accounts Payable
Cash	786,151
Cash	(786,151)
TDI | Business Acquisition, Accrued Expenses
Cash	53,857
Cash	(53,857)
TDI | Business Acquisition, Contract liability
Cash	2,334,188
Cash	(2,334,188)
TDI | Business Acquisition, Notes Payable
Cash	64,733
Cash	(64,733)
TDI | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	6,354,000
TDI | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	1,102,394
Alt Labs
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	11,902,677
Alt Labs | Business Acquisition, Accounts Receivable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Property and Equipment
Cash	1,739,441
Cash	(1,739,441)
Alt Labs | Business Acquisition Intangible Assets
Cash	10,410,000
Cash	(10,410,000)
Alt Labs | Business Acquisition, Goodwill
Cash	252,851
Cash	(252,851)
Alt Labs | Business Acquisition, Accounts Payable
Cash	397,441
Cash	(397,441)
Alt Labs | Business Acquisition, Accrued Expenses
Cash	62,242
Cash	(62,242)
Alt Labs | Business Acquisition, Contract liability
Cash	1,754,290
Cash	(1,754,290)
Alt Labs | Business Acquisition, Notes Payable
Cash	1,695,238
Cash	(1,695,238)
Alt Labs | Business Acquisition, Cash
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	10,470,000
Alt Labs | Business Acquisition, Inventory
Cash	2,621,653
Cash	(2,621,653)
Alt Labs | Business Acquisition, Other Asset
Cash	390,502
Cash	(390,502)
Alt Labs | Common Class A
Business Acquisitions, Purchase Price Allocation, Year of Acquisition, Net Effect on Income	$ 1,432,677

Note 8 - Business Combination_4

Note 8 - Business Combination: Business Acquisition, Pro Forma Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Sales	$ 17,373,627	$ 16,477,880	$ 32,067,366	$ 35,078,054
Cost of goods sold	11,777,452	10,998,610	23,079,773	25,069,719
Gross profit	5,596,175	5,479,270	8,987,593	10,008,335
Operating Expenses	7,545,036	6,693,374	14,508,183	11,899,041
Loss from operations	(1,948,861)	(1,214,104)	(5,520,590)	(1,890,706)
Net loss	$ (1,748,773)	$ (2,162,795)	$ (6,374,489)	$ (1,397,730)
Loss per share	$ (0.01)	$ (0.02)	$ (0.04)	$ (0.01)

Note 9 - Industry Segments_ S_2

Note 9 - Industry Segments: Schedule of Segment Reporting Information, by Segment (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Revenue	$ 14,130,730		$ 9,042,864		$ 22,540,269	$ 17,878,460
Gross Profit	3,964,060		1,956,016		4,718,679	3,715,760
Loss from operations	(2,904,217)		(1,606,197)		(7,976,286)	(2,709,842)
Interest Expense	1,216,587		905,842		2,688,310	2,555,069
Net loss	(3,127,277)	$ (6,129,468)	(2,562,914)	$ 250,388	(9,256,745)	(2,312,526)
TOTAL ASSETS	94,027,836				94,027,836		$ 40,734,183
Goodwill	5,866,454				5,866,454		2,084,982
Accounts receivable, net	10,328,941				10,328,941		6,484,869
QCA
Revenue	4,441,919		2,353,502		8,180,228	4,383,628
Gross Profit	1,252,086		629,684		2,164,363	1,135,466
Loss from operations	460,554		148,185		784,385	39,033
Depreciation, Depletion and Amortization, Nonproduction	203,642		67,723		327,587	121,704
Interest Expense	125,959		126,697		264,238	247,142
Net loss	349,578		20,141		514,544	(165,549)
TOTAL ASSETS	12,909,816				12,909,816		9,574,237
Goodwill	1,963,761				1,963,761		1,963,761
Accounts receivable, net	3,477,482				3,477,482		1,938,446
APF
Revenue	0		1,256,375		0	1,785,416
Gross Profit	0		200,347		0	170,705
Loss from operations	(39,445)		(1,089,485)		(109,087)	(1,317,929)
Depreciation, Depletion and Amortization, Nonproduction	38,974		71,960		78,388	143,921
Interest Expense	320		55,067		4,397	135,011
Net loss	(39,765)		(1,015,231)		(113,484)	(1,380,346)
TOTAL ASSETS	1,033,430				1,033,430		1,157,699
Accounts receivable, net	45,022				45,022		45,022
Morris
Revenue	3,442,625		2,516,499		6,572,281	5,771,426
Gross Profit	780,702		550,829		1,127,701	1,180,452
Loss from operations	164,962		192,197		(102,941)	383,064
Depreciation, Depletion and Amortization, Nonproduction	158,754		173,326		242,571	324,590
Interest Expense	96,718		210,672		189,430	585,072
Net loss	107,661		(12,015)		(247,426)	308,397
TOTAL ASSETS	9,520,054				9,520,054		6,881,599
Goodwill	113,592				113,592		113,592
Accounts receivable, net	3,066,332				3,066,332		1,944,269
Deluxe
Revenue	1,422,984		1,509,104		2,300,797	3,903,268
Gross Profit	55,372		(104,978)		(691,193)	409,217
Loss from operations	(448,061)		(386,211)		(2,114,020)	(306,249)
Depreciation, Depletion and Amortization, Nonproduction	182,931		175,111		365,861	351,361
Interest Expense	142,938		137,085		326,771	394,287
Net loss	229,012		(523,293)		(1,620,938)	(602,599)
TOTAL ASSETS	10,842,897				10,842,897		12,039,414
Accounts receivable, net	1,060,541				1,060,541		2,015,745
Excel
Revenue	562,612		1,407,384		1,226,373	2,034,722
Gross Profit	35,786		680,134		277,694	819,920
Loss from operations	(469,632)		478,571		(639,572)	257,611
Depreciation, Depletion and Amortization, Nonproduction	79,641		57,162		145,616	87,968
Interest Expense	60,978		129,174		166,269	177,029
Net loss	(530,610)		349,397		(805,841)	80,582
TOTAL ASSETS	3,762,088				3,762,088		3,727,168
Goodwill	7,629				7,629		7,629
Accounts receivable, net	592,438				592,438		541,387
TDI
Revenue	1,145,105		0		1,145,105	0
Gross Profit	460,218		0		460,218	0
Loss from operations	3,622		0		3,622	0
Depreciation, Depletion and Amortization, Nonproduction	56,217		0		56,217	0
Interest Expense	825		0		825	0
Net loss	6,384		0		6,384	0
TOTAL ASSETS	11,047,236				11,047,236		0
Goodwill	3,528,621				3,528,621		0
Accounts receivable, net	1,199,925				1,199,925		0
Alt Labs
Revenue	3,115,485		0		3,115,485	0
Gross Profit	1,379,896		0		1,379,896	0
Loss from operations	56,840		0		56,840	0
Depreciation, Depletion and Amortization, Nonproduction	173,648		0		173,648	0
Interest Expense	240		0		240	0
Net loss	56,599		0		56,599	0
TOTAL ASSETS	20,962,466				20,962,466		0
Goodwill	252,851				252,851		0
Accounts receivable, net	887,201				887,201		0
IA and Vayu
Loss from operations	(705,398)		0		(2,923,177)	0
Depreciation, Depletion and Amortization, Nonproduction	48,124		0		226,368	0
Net loss	(705,407)		0		(2,493,646)	0
Unallocated and Eliminations
Loss from operations	(1,927,659)		(949,454)		(2,932,336)	(1,765,372)
Depreciation, Depletion and Amortization, Nonproduction	8,807		0		56,908	0
Interest Expense	788,609		247,147		1,736,140	1,016,528
Net loss	(2,600,729)		$ (1,381,913)		(4,552,937)	$ (553,011)
TOTAL ASSETS	9,145,584				9,145,584		1,011,203
IA
TOTAL ASSETS	$ 14,804,265				$ 14,804,265		$ 6,342,863